The following regimens recommended added as Other Recommended for adenocarcinoma, large cell, NSCLC NOS….Tremelimumab-actl + durvalumab + carboplatin + albumin-bound paclitaxel...Tremelimumab-actl + durvalumab + (carboplatin or cisplatin) + pemetrexed